STOCK TITAN

OraSure Technologies (OSUR) CFO adds 32,300 shares in planned buy

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

OraSure Technologies Chief Financial Officer Kenneth J. McGrath reported an open-market purchase of 32,300 shares of common stock. The trade occurred on March 20, 2026 at a weighted average price of $2.9288 per share, with individual prices ranging from $2.86 to $2.98.

After this transaction, McGrath directly holds 589,562 OraSure shares. The purchase was carried out under a pre-arranged Rule 10b5-1 trading plan that he adopted on November 28, 2025, indicating the buying activity was scheduled in advance rather than timed discretionarily.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McGrath Kenneth J

(Last)(First)(Middle)
C/O ORASURE TECHNOLOGIES, INC.
220 EAST FIRST STREET

(Street)
BETHLEHEM PENNSYLVANIA 18015

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ORASURE TECHNOLOGIES INC [ OSUR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/20/2026P32,300(1)A$2.9288(2)589,562D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2025.
2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.86 to $2.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Michele Anthony, Attorney-In-Fact03/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did OraSure Technologies (OSUR) report in this Form 4?

OraSure Technologies reported that CFO Kenneth J. McGrath bought 32,300 shares of common stock. The open-market purchase occurred on March 20, 2026 at a weighted average price of $2.9288 per share, reflecting a planned increase in his direct holdings.

At what prices did OraSure (OSUR) CFO Kenneth McGrath buy his shares?

Kenneth McGrath’s purchase had a weighted average price of $2.9288 per share. According to the filing, individual trades were executed in a range from $2.86 to $2.98 per share, all as part of the same open-market buying program.

How many OraSure (OSUR) shares does the CFO own after this reported transaction?

Following the reported purchase, CFO Kenneth McGrath directly holds 589,562 OraSure common shares. This total includes the newly acquired 32,300 shares bought on March 20, 2026, as disclosed in the Form 4 insider ownership table.

Was the OraSure (OSUR) CFO’s share purchase made under a Rule 10b5-1 plan?

Yes. The filing states that the transactions were executed under a Rule 10b5-1 trading plan. This plan was adopted by CFO Kenneth McGrath on November 28, 2025, meaning the purchases were pre-scheduled rather than spontaneously timed with market conditions.

What does the Rule 10b5-1 trading plan mean for this OraSure (OSUR) insider trade?

A Rule 10b5-1 trading plan allows insiders to prearrange stock trades while limiting timing discretion. For OraSure, the filing notes McGrath’s plan was adopted November 28, 2025, so the March 20, 2026 purchases followed that preset schedule and parameters.

What type of security did OraSure (OSUR) CFO Kenneth McGrath purchase?

Kenneth McGrath bought OraSure’s common stock in this transaction. The Form 4 classifies the activity as a non-derivative, open-market purchase, distinguishing it from option exercises or other derivative-related transactions often seen in insider filings.
Orasure Tech

NASDAQ:OSUR

View OSUR Stock Overview

OSUR Rankings

OSUR Latest News

OSUR Latest SEC Filings

OSUR Stock Data

212.22M
64.36M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BETHLEHEM